The impact of prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and maternal mood on mother-infant interactions at 3 months of age

Infant Behavior and Development

Volumn 36, Issue 4, 2013, Pages 485-493

  Weikum, Whitney M ^a   Mayes, Linda C ^b   Grunau, Ruth E ^a   Brain, Ursula ^a   Oberlander, Tim F ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Infant development; Maternal depression; Mother infant interaction; Prenatal exposure; Serotonin reuptake inhibitor

Indexed keywords

CITALOPRAM; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADULT; ARTICLE; CHILD BEHAVIOR; CHILD DEVELOPMENT; CLINICAL ARTICLE; CONTROLLED STUDY; EMOTIONALITY; FEMALE; FETUS RISK; GESTATIONAL AGE; HUMAN; INFANT; MALE; MATERNAL ATTITUDE; MOTHER CHILD RELATION; PLAY; PREDICTION; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PUERPERAL DEPRESSION; SCORING SYSTEM; SOCIAL EVOLUTION; VIDEORECORDING;

INFANT DEVELOPMENT; MATERNAL DEPRESSION; MOTHER-INFANT INTERACTION; PRENATAL EXPOSURE; SEROTONIN REUPTAKE INHIBITOR;

ADULT; AFFECT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; FEMALE; HUMANS; INFANT; MALE; MATERNAL BEHAVIOR; MOTHER-CHILD RELATIONS; MOTHERS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SEROTONIN UPTAKE INHIBITORS;

EID: 84878588857     PISSN: 01636383     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.infbeh.2013.04.001     Document Type: Article

References (51)

1. Abrams S.M., Field T., Scafidi F., Prodromidis M. Newborns of depressed mothers. Infant Mental Health Journal 1995, 16(3):233-239.
2. Ainsworth M.S. Infant-mother attachment. American Psychologist 1979, 34(10):932-937.
3. Allister L., Lester B.M., Carr S., Liu J. The effects of maternal depression on fetal heart rate response to vibroacoustic stimulation. Developmental Neuropsychology 2001, 20(3):639-651.
4. Austin M.P., Priest S. Clinical issues in perinatal mental health: New developments in the detection and treatment of perinatal mood and anxiety disorders. Acta Psychiatrica Scandinavica 2005, 112(2):97-104.
5. Barker E., Blakely R. Norepinephrine and serotonin transporters: Molecular targets of antidepressant drugs. Psychopharmacology: The Fourth Generation of Progress 1995, 28:321-333.
6. Bellantuono C., Migliarese G., Gentile S. Serotonin reuptake inhibitors in pregnancy and the risk of major malformations: A systematic review. Human Psychopharmacology: Clinical and Experimental 2007, 22(3):121-128.
7. Campbell S.B., Cohn J.F., Meyers T. Depression in first-time mothers: Mother-infant interaction and depression chronicity. Developmental Psychology 1995, 31(3):349-357.
8. Cohn J.F., Matias R., Tronick E.Z., Lyons-Ruth D., Connell D. Face-to-face interactions, spontaneous and structured, of mothers with depressive symptoms. Maternal depression and child development (New Directions for Child Development) 1986, 31-46. Jossey-Bass, San Francisco. T. Field, E. Z: Tronick (Eds.).
9. Cooper W.O., Willy M.E., Pont S.J., Ray W.A. Increasing use of antidepressants in pregnancy. American Journal of Obstetrics and Gynecology 2007, 196(6). 544.e1-544.e5.
10. Davis E.P., Glynn L.M., Schetter C.D., Hobel C., Chicz-Demet A., Sandman C.A. Prenatal exposure to maternal depression and cortisol influences infant temperament. Journal of the American Academy of Child & Adolescent Psychiatry 2007, 46(6):737-746.
11. DiPietro J.A., Novak M.F.S.X., Costigan K.A., Atella L.D., Reusing S.P. Maternal psychological distress during pregnancy in relation to child development at age two. Child Development 2006, 77(3):573-587.
12. DiPietro J.A., Hodgson D.M., Costigan K.A., Hilton S.C., Johnson T.R.B. Fetal neurobehavioral development. Child Development 1996, 67(5):2553-2567.
13. Egeland B., Pianta R., O'brien M.A. Maternal intrusiveness in infancy and child maladaptation in early school years. Development and Psychopathology 1993, 5. 359-359.
14. Feldman R. Coding interactive behavior (CIB) manual. Unpublished Manual 1998, Bar-Ilan University.
15. Field T. Postpartum depression effects on early interactions, parenting, and safety practices: A review. Infant Behavior and Development 2010, 33(1):1-6.
16. Field T., Diego M., Hernandez-Reif M. Prenatal depression effects on the fetus and newborn: A review. Infant Behavior and Development 2006, 29(3):445-455.
17. Field T., Healy B.T., Goldstein S., Guthertz M. Behavior-state matching and synchrony in mother-infant interactions of nondepressed versus depressed dyads. Developmental Psychology 1990, 26(1):7-14.
18. Field T.M. Early interactions between infants and their postpartum depressed mothers. Infant Behavior and Development 1984, 7:527-532.
19. Gaspar P., Cases O., Maroteaux L. The developmental role of serotonin: News from mouse molecular genetics. Nature Reviews Neuroscience 2003, 4(12):1002-1012.
20. Gentile S. SSRIs in pregnancy and lactation: Emphasis on neurodevelopmental outcome. CNS Drugs 2005, 19(7):623-633.
21. Glover V. Annual research review: Prenatal stress and the origins of psychopathology: An evolutionary perspective. Journal of Child Psychology and Psychiatry 2011, 52(4):356-367.
22. Gluckman P.D., Hanson M.A., Beedle A.S. Early life events and their consequences for later disease: A life history and evolutionary perspective. American Journal of Human Biology 2007, 19(1):1-19.
23. Gluckman P.D., Hanson M.A., Spencer H.G., Bateson P. Environmental influences during development and their later consequences for health and disease: Implications for the interpretation of empirical studies. Proceedings of the Royal Society B: Biological Sciences 2005, 272(1564):671-677.
24. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry 1960, 23(1):56-62.
25. Kim J., Riggs K.W., Misri S., Kent N., Oberlander T.F., Grunau R.E., Rurak D.W. Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding. British Journal of Clinical Pharmacology 2006, 61(2):155-163.
26. Lovejoy M.C., Graczyk P.A., O'Hare E., Neuman G. Maternal depression and parenting behavior: A meta-analytic review. Clinical Psychology Review 2000, 20(5):561-592.
27. Martins C., Gaffan E.A. Effects of early maternal depression on patterns of infant-mother attachment: A meta-analytic investigation. Journal of Child Psychology and Psychiatry 2000, 41(6):737-746.
28. Mayes L.C., Feldman R., Granger R.H., Haynes O.M., Bornstein M.H., Schottenfeld R. The effects of polydrug use with and without cocaine on mother-infant interaction at 3 and 6 months. Infant Behavior and Development 1997, 20(4):489-502.
29. Monk C., Fifer W.P., Myers M.M., Sloan R.P., Trien L., Hurtado A. Maternal stress responses and anxiety during pregnancy: Effects on fetal heart rate. Developmental Psychobiology 2000, 36(1):67-77.
30. Moses-Kolko E.L., Bogen D., Perel J., Bregar A., Uhl K., Levin B., Wisner K.L. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors. The Journal of the American Medical Association 2005, 293(19):2372-2383.
31. Murray L., Fiori-Cowley A., Hooper R., Cooper P. The impact of postnatal depression and associated adversity on early mother-infant interactions and later infant outcome. Child Development 1996, 67(5):2512-2526.
32. Murray L., Hipwell A., Hooper R., Stein A., Cooper P. The cognitive development of 5-year-old children of postnatally depressed mothers. Journal of Child Psychology and Psychiatry 1996, 37(8):927-935.
33. Nordeng H., Spigset O. Treatment with selective serotonin reuptake inhibitors in the third trimester of pregnancy: Effects on the infant. Drug Safety 2005, 28(7):565-581.
34. Oberlander T.F., Warburton W., Misri S., Aghajanian J., Hertzman C. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Archives of General Psychiatry 2006, 63(8):898-906.
35. Oberlander T., Gingrich J., Ansorge M. Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: Molecular to clinical evidence. Clinical Pharmacology & Therapeutics 2009, 86(6):672-677.
36. Olson S.L., Bates J.E., Bayles K. Mother-infant interaction and the development of individual differences in children's cognitive competence. Developmental Psychology 1984, 20(1):166-179.
37. Pawluski J.L., Galea L.A., Brain U., Papsdorf M., Oberlander T.F. Pediatrics 2009, 124(4):e662-e670.
38. Pederson D.R., Gleason K.E., Moran G., Bento S. Maternal attachment representations, maternal sensitivity, and the infant-mother attachment relationship. Developmental Psychology 1998, 34(5):925-933.
39. Pluess M., Velders F.P., Belsky J., van IJzendoorn M.H., Bakermans-Kranenburg M.J., Jaddoe V.W.V., Tiemeier H. Serotonin transporter polymorphism moderates effects of prenatal maternal anxiety on infant negative emotionality. Biological Psychiatry 2011, 69(6):520-525.
40. Porter R.J., Gallagher P., Thompson J.M., Young A.H. Neurocognitive impairment in drug-free patients with major depressive disorder. The British Journal of Psychiatry 2003, 182(3):214-220.
41. Reebye P.N., Morison S.J., Panikkar H., Misri S., Grunau R.E. Affect expression in prenatally psychotropic exposed and nonexposed mother-infant dyads. Infant Mental Health Journal 2002, 23(4):403-416.
42. Rush A.J., Trivedi M.H., Wisniewski S.R., Stewart J.W., Nierenberg A.A., Thase M.E., Luther J.F. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. New England Journal of Medicine 2006, 354(12):1231-1242.
43. Sandman C.A., Davis E.P., Glynn L.M. Prescient human fetuses thrive. Psychological Science 2012, 23(1):93-100.
44. Simon G.E., Cunningham M.L., Davis R.L. Outcomes of prenatal antidepressant exposure. American Journal of Psychiatry 2002, 159(12):2055-2061.
45. Talge N.M., Neal C., Glover V. Antenatal maternal stress and long-term effects on child neurodevelopment: How and why?. Journal of Child Psychology and Psychiatry 2007, 48(3-4):245-261.
46. Tronick E.Z., Cohn J.F. Infant-mother face-to-face interaction: Age and gender differences in coordination and the occurrence of miscoordination. Child Development 1989, 60(1):85-92.
47. Tronick E.Z., Weinberg K. Depressed mothers and infants: the failure to form dyadic states of consciousness. Post-partum depression and child development 1997, 54-85. Guilford, New York. L. Murray, P. Cooper (Eds.).
48. VanderWeele T.J., Mumford S.L., Schisterman E.F. Conditioning on intermediates in perinatal epidemiology. Epidemiology 2012, 23(1):1-9.
49. Weikum W.M., Oberlander T.F., Hensch T.K., Werker J.F. Prenatal exposure to antidepressants and depressed maternal mood alter trajectory of infant speech perception. Proceedings of the National Academy of Sciences, USA, vol. 109 (supplement 2) 2012, 17221-17227.
50. Weinberg M.K., Tronick E.Z. The impact of maternal psychiatric illness on infant development. Journal of Clinical Psychiatry 1998, 59(2):53-61.
51. Wolff M.S., Ijzendoorn M.H. Sensitivity and attachment: A meta-analysis on parental antecedents of infant attachment. Child Development 1997, 68(4):571-591.